[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-001", "question": "A 65-year-old male with ARDS is deeply sedated and paralyzed on volume-control ventilation. Paralysis is paused for a 'sedation holiday.' The ventilator waveform display subsequently shows a controlled breath delivered by the machine, followed immediately by a deflection in the flow waveform suggesting patient effort, which then triggers a second, stacked breath. Esophageal manometry reveals that the diaphragm electrical activity (EAdi) and negative esophageal pressure swing onset occur *after* the initiation of the first machine-delivered breath. What is the specific dyssynchrony described?", "options": ["Double triggering", "Reverse triggering", "Ineffective triggering", "Autocycling", "Flow starvation"], "answer": "B", "answer_index": 1, "explanation": "This is reverse triggering (entrainment). Unlike double triggering (where a sustained patient effort triggers two breaths), reverse triggering is a reflex where the mechanical inflation of the lung stretches the diaphragm, inducing a muscle contraction *after* the breath has started. This contraction can then trigger a second breath (breath stacking). The key distinction is the timing of the patient's effort relative to the machine cycle.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "Let me analyze this step by step.\n\nThe key findings in this case are:\n1. Patient is on volume-control ventilation after paralysis was paused\n2. A controlled breath is delivered by the machine\n3. This is followed by patient effort (deflection in flow waveform)\n4. The patient effort triggers a second, stacked breath\n5. Critically: Esophageal manometry shows that diaphragm electrical activity (EAdi) and negative esophageal pressure swing occur *AFTER* the initiation of the first machine-delivered breath\n\nThis timing is crucial - the patient's respiratory effort is occurring in response to (after) the machine breath, not before it.\n\nLet me consider each option:\n\nA. Double triggering - This occurs when patient effort triggers two consecutive breaths, but typically the patient effort initiates the first breath.\n\nB. Reverse triggering - This is when a machine-delivered breath causes/entrains patient respiratory effort. The mechanical breath stimulates the respiratory center, causing diaphragmatic contraction AFTER the breath has started. This can lead to breath stacking.\n\nC. Ineffective triggering - This is when patient effort fails to trigger a breath.\n\nD. Autocycling - This is when the ventilator delivers breaths without any patient effort, usually due to circuit leaks or cardiac oscillations.\n\nE. Flow starvation - This occurs when inspiratory flow is insufficient to meet patient demand.\n\nThe hallmark of this case is that the patient's neural respiratory drive (EAdi) and mechanical effort (negative esophageal pressure) occur AFTER the machine breath starts. This is the defining characteristic of reverse triggering - the ventilator breath entrains/triggers the patient's respiratory effort, which can then trigger a second breath (breath stacking).\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-002", "question": "A 72-year-old male presents with macrocytic anemia, intermittent fevers, and relapsing polychondritis resistant to standard immunosuppression. Bone marrow biopsy reveals vacuoles in myeloid and erythroid precursor cells. Cytogenetics are normal. Which of the following genetic mutations is most likely responsible for this clinical syndrome?", "options": ["JAK2 V617F", "UBA1", "SF3B1", "TET2", "MYD88"], "answer": "B", "answer_index": 1, "explanation": "The patient has VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), a recently described disorder caused by somatic mutations in the UBA1 gene. It typically affects older men and presents with treatment-refractory inflammatory symptoms (chondritis, vasculitis) and hematologic abnormalities (macrocytic anemia, vacuoles in marrow precursors).", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nThe patient presents with:\n- 72-year-old male\n- Macrocytic anemia\n- Intermittent fevers\n- Relapsing polychondritis resistant to standard immunosuppression\n- Bone marrow biopsy showing vacuoles in myeloid and erythroid precursor cells\n- Normal cytogenetics\n\nThis clinical presentation is classic for VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic).\n\nKey features of VEXAS syndrome:\n- Typically affects older males (X-linked somatic mutation)\n- Characterized by vacuoles in myeloid and erythroid precursors on bone marrow biopsy\n- Associated with inflammatory conditions including relapsing polychondritis, Sweet syndrome, and other autoinflammatory manifestations\n- Macrocytic anemia and cytopenias\n- Often refractory to standard immunosuppressive therapy\n- Normal cytogenetics\n\nVEXAS syndrome is caused by somatic mutations in the UBA1 gene, which encodes the E1 ubiquitin-activating enzyme. This mutation leads to both hematologic abnormalities and systemic inflammation.\n\nLet me rule out other options:\n- JAK2 V617F: Associated with myeloproliferative neoplasms\n- SF3B1: Associated with MDS with ring sideroblasts\n- TET2: Associated with clonal hematopoiesis and various myeloid neoplasms\n- MYD88: Associated with Waldenström macroglobulinemia and lymphoplasmacytic lymphoma\n\nThe combination of relapsing polychondritis, macrocytic anemia, vacuoles in precursor cells, and treatment-resistant inflammation in an older male is pathognomonic for VEXAS syndrome caused by UBA1 mutation.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-003", "question": "A 45-year-old victim of a residential fire is intubated for airway protection. Due to suspected cyanide toxicity, a specific antidote is administered. Two hours later, the patient requires continuous renal replacement therapy (CRRT) for severe acidosis and acute kidney injury. Shortly after initiation, the CRRT machine repeatedly alarms and stops due to a 'Blood Leak' error, despite visual inspection of the effluent showing no frank blood. What is the mechanism of this technical complication?", "options": ["Hemolysis induced by the antidote", "Rhabdomyolysis myoglobin filtering", "Optical interference by the antidote", "Precipitation of antidote in the filter", "Coagulation of the filter membrane"], "answer": "C", "answer_index": 2, "explanation": "The patient received hydroxocobalamin (cyanokit), which has an intense red color. This chromophore passes into the ultrafiltrate/dialysate and is detected by the optical blood leak detector of the dialysis machine, causing a false-positive alarm that halts therapy. It also interferes with co-oximetry (falsely elevating HbCO) and colorimetric chemistry labs (creatinine, lactate) for days.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let me work through this step by step.\n\nThe patient has suspected cyanide toxicity from a residential fire. The specific antidote for cyanide toxicity that would be administered is hydroxocobalamin (Cyanokit).\n\nHydroxocobalamin is a deep red/burgundy colored compound. When administered, it causes the patient's body fluids (blood, urine, tears, sweat) to turn a distinctive red color.\n\nThe CRRT machine is alarming for \"Blood Leak\" despite no visible frank blood in the effluent. Blood leak detectors in CRRT machines work by using optical sensors that detect the color/light absorption characteristics of blood (specifically hemoglobin's red color) in the effluent.\n\nHydroxocobalamin's deep red color can interfere with these optical blood leak detectors. The machine's sensor detects the red coloration from the hydroxocobalamin and interprets it as blood, triggering the blood leak alarm - even though there is no actual blood leak.\n\nThis is a well-documented phenomenon with hydroxocobalamin administration. The red discoloration of body fluids can persist for days and causes false-positive blood leak alarms on dialysis machines.\n\nLet me review the options:\n- A. Hemolysis induced by the antidote - Hydroxocobalamin doesn't typically cause hemolysis\n- B. Rhabdomyolysis myoglobin filtering - While possible in fire victims, this wouldn't explain the specific scenario with the antidote\n- C. Optical interference by the antidote - This matches the mechanism of hydroxocobalamin's red color interfering with the optical blood leak detector\n- D. Precipitation of antidote in the filter - Not a known issue with hydroxocobalamin\n- E. Coagulation of the filter membrane - This would cause different alarms (pressure alarms)\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-004", "question": "A 3-week-old infant presents with a large, firm, violaceous, indurated plaque on the thigh that has rapidly expanded. Labs reveal profound thrombocytopenia (12,000/microL), hypofibrinogenemia, and elevated D-dimer. The attending physician diagnoses Kasabach-Merritt Phenomenon. Which of the following underlying vascular anomalies is most strongly associated with this complication?", "options": ["Infantile Hemangioma", "Kaposiform Hemangioendothelioma", "Venous Malformation", "Pyogenic Granuloma", "Port-wine Stain"], "answer": "B", "answer_index": 1, "explanation": "Kasabach-Merritt Phenomenon (KMP) is a life-threatening consumptive coagulopathy. Historically, it was incorrectly associated with common Infantile Hemangiomas. It is now known to be exclusively associated with rare, aggressive vascular tumors, specifically Kaposiform Hemangioendothelioma (KHE) and Tufted Angioma. Common infantile hemangiomas do *not* cause KMP.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "Let me work through this question about Kasabach-Merritt Phenomenon (KMP).\n\nKasabach-Merritt Phenomenon is a life-threatening condition characterized by:\n- Profound thrombocytopenia\n- Consumptive coagulopathy (hypofibrinogenemia, elevated D-dimer)\n- Associated with specific vascular tumors\n\nThe clinical presentation described - a large, firm, violaceous, indurated plaque that rapidly expands in a young infant with severe thrombocytopenia and coagulopathy - is classic for KMP.\n\nLet me evaluate each option:\n\nA. Infantile Hemangioma - This is a common misconception. While infantile hemangiomas are the most common vascular tumors of infancy, they are NOT associated with KMP. This is an important distinction that has been clarified in recent literature.\n\nB. Kaposiform Hemangioendothelioma (KHE) - This is a rare, locally aggressive vascular tumor that is strongly associated with KMP. KHE typically presents as a firm, violaceous, indurated plaque and is the most common cause of KMP. Tufted angioma is the other tumor associated with KMP.\n\nC. Venous Malformation - This is a slow-flow vascular malformation that can cause localized intravascular coagulopathy (LIC) but not the severe thrombocytopenia seen in KMP.\n\nD. Pyogenic Granuloma - This is a benign vascular lesion that does not cause KMP.\n\nE. Port-wine Stain - This is a capillary malformation that does not cause KMP.\n\nThe key teaching point is that KMP is specifically associated with Kaposiform Hemangioendothelioma and Tufted Angioma, NOT infantile hemangiomas (despite the historical confusion in terminology).\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-005", "question": "A 58-year-old female presents with a 6-month history of progressive gait instability, dysarthria, and severe sleep dysfunction characterized by undifferentiated NREM/REM sleep and stridor. MRI brain is unremarkable. CSF analysis shows normal cell count and protein. Testing for which of the following antibodies is most likely to yield the diagnosis?", "options": ["Anti-Hu", "Anti-Yo", "Anti-IgLON5", "Anti-LGI1", "Anti-GABA-B"], "answer": "C", "answer_index": 2, "explanation": "Anti-IgLON5 disease is a distinct neurological syndrome characterized by a unique sleep disorder (parasomnias, sleep apnea, stridor) and bulbar dysfunction/gait instability. It is a tauopathy that bridges the gap between autoimmunity and neurodegeneration. The sleep architecture is often severely disorganized.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nThe patient presents with:\n- Progressive gait instability\n- Dysarthria\n- Severe sleep dysfunction with undifferentiated NREM/REM sleep\n- Stridor (suggesting brainstem involvement)\n- Unremarkable MRI\n- Normal CSF\n\nThe key distinguishing features here are:\n1. Sleep dysfunction with undifferentiated NREM/REM sleep - This is a very specific finding\n2. Stridor - indicates upper airway/brainstem dysfunction\n3. Gait instability and dysarthria - brainstem/cerebellar involvement\n4. Normal MRI and CSF - rules out many inflammatory conditions\n\nLet me consider each option:\n\nAnti-Hu: Associated with sensory neuronopathy, limbic encephalitis, cerebellar degeneration. Typically paraneoplastic with small cell lung cancer.\n\nAnti-Yo: Associated with cerebellar degeneration, typically in women with ovarian or breast cancer.\n\nAnti-IgLON5: This is the key antibody. Anti-IgLON5 disease is characterized by:\n- Complex sleep disorder with undifferentiated NREM/REM sleep (parasomnia, sleep apnea)\n- Stridor and obstructive sleep apnea\n- Bulbar symptoms (dysarthria, dysphagia)\n- Gait instability\n- Often normal or near-normal MRI\n- CSF can be normal or show mild abnormalities\n\nAnti-LGI1: Associated with limbic encephalitis, faciobrachial dystonic seizures, hyponatremia.\n\nAnti-GABA-B: Associated with limbic encephalitis, seizures, often with small cell lung cancer.\n\nThe combination of undifferentiated NREM/REM sleep, stridor, gait instability, dysarthria, with normal MRI and CSF is classic for Anti-IgLON5 disease. This is a relatively recently described autoimmune condition with a unique sleep phenotype.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-006", "question": "A patient with severe chronic hyponatremia (Na 105 mEq/L) and concomitant hypokalemia (K 2.5 mEq/L) is admitted. The resident orders 40 mEq of IV KCl to correct the potassium. Two hours later, the serum sodium has risen to 112 mEq/L, exceeding the safe correction limit. What is the primary physiological mechanism for this rapid rise in serum sodium?", "options": ["Osmotic demyelination releasing sodium", "Intracellular sodium shift in exchange for potassium", "Aldosterone suppression", "Volume expansion suppression of ADH", "Renal sodium retention"], "answer": "B", "answer_index": 1, "explanation": "Administered potassium enters cells to replenish intracellular stores; to maintain electroneutrality, sodium exits the cells into the extracellular space. Therefore, potassium administration acts osmotically equivalent to sodium administration in raising serum tonicity. Additionally, correcting hypokalemia may improve renal concentrating ability, but the cation exchange is the immediate cause of the rapid sodium rise.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "Let me work through this problem step by step.\n\nThe patient has severe hyponatremia (Na 105 mEq/L) and hypokalemia (K 2.5 mEq/L). After IV potassium replacement, the sodium rose rapidly from 105 to 112 mEq/L (7 mEq/L increase in 2 hours), which exceeds safe correction limits.\n\nThe key question is: why does potassium replacement cause a rapid rise in serum sodium?\n\nLet me analyze each option:\n\nA. Osmotic demyelination releasing sodium - This is a complication of rapid sodium correction, not a cause of it. It occurs days after overcorrection.\n\nB. Intracellular sodium shift in exchange for potassium - This describes sodium moving INTO cells in exchange for potassium moving OUT. This would actually LOWER serum sodium, not raise it.\n\nC. Aldosterone suppression - This would lead to sodium loss, not sodium retention.\n\nD. Volume expansion suppression of ADH - 40 mEq KCl is a small volume and wouldn't significantly suppress ADH through volume expansion.\n\nE. Renal sodium retention - This doesn't explain the mechanism related to potassium replacement.\n\nThe correct mechanism is actually the opposite of option B. When potassium is administered:\n- Potassium enters cells\n- To maintain electroneutrality, sodium exits cells (or hydrogen ions exit)\n- This raises serum sodium concentration\n\nHowever, looking at option B more carefully - it says \"Intracellular sodium shift in exchange for potassium.\" This is poorly worded, but the concept being tested is the Na-K exchange across cell membranes.\n\nActually, the primary mechanism is: Potassium and sodium are both osmotically active cations. When you give potassium, it enters cells. The body's total effective osmoles increase. Since potassium is effectively an osmole like sodium, giving potassium is similar to giving sodium in terms of its effect on water distribution. The tonicity formula includes both Na and K: Effective osmolality ≈ 2(Na + K).\n\nWhen K enters cells, Na tends to leave cells to maintain electrochemical balance, raising serum sodium. Option B, despite its confusing wording, refers to this exchange mechanism.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-007", "question": "A 14-year-old male presents with delayed umbilical stump bleeding as a neonate and now has a history of poor wound healing and recurrent soft tissue hematomas. Standard coagulation screening tests (PT, aPTT, fibrinogen, platelet count) are all consistently normal. A urea solubility test is performed and shows clot dissolution. Which factor deficiency is the diagnosis?", "options": ["Factor VIII", "Factor IX", "Factor XI", "Factor XIII", "Alpha-2-antiplasmin"], "answer": "D", "answer_index": 3, "explanation": "Factor XIII (Fibrin Stabilizing Factor) is responsible for cross-linking fibrin monomers. Deficiency leads to unstable clots that dissolve in 5M urea (or monochloroacetic acid). Because the coagulation cascade up to the formation of the fibrin polymer is intact, the standard PT and aPTT are normal. The clinical hallmark is delayed bleeding (e.g., umbilical stump) and poor wound healing.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n- Delayed umbilical stump bleeding as a neonate\n- Poor wound healing\n- Recurrent soft tissue hematomas\n- Normal PT, aPTT, fibrinogen, and platelet count\n- Positive urea solubility test (clot dissolution)\n\nAnalysis of the findings:\n\nThe normal PT and aPTT rule out deficiencies in the intrinsic and extrinsic coagulation pathways, which would include:\n- Factor VIII deficiency (Hemophilia A) - would cause prolonged aPTT\n- Factor IX deficiency (Hemophilia B) - would cause prolonged aPTT\n- Factor XI deficiency - would cause prolonged aPTT\n\nThe urea solubility test is the critical diagnostic clue here. This test specifically evaluates Factor XIII function. Factor XIII is a transglutaminase that cross-links fibrin monomers to form a stable clot. Without Factor XIII:\n- Initial clot formation occurs normally (hence normal PT/aPTT)\n- The clot is unstable and dissolves in 5M urea or 1% monochloroacetic acid\n- A normal clot (with proper Factor XIII cross-linking) remains stable in urea\n\nFactor XIII deficiency classically presents with:\n- Delayed umbilical cord bleeding (very characteristic - occurs in ~80% of cases)\n- Poor wound healing\n- Soft tissue bleeding/hematomas\n- Normal routine coagulation tests\n\nAlpha-2-antiplasmin deficiency can also cause clot dissolution and bleeding, but the classic presentation with umbilical stump bleeding and the urea solubility test pattern is most characteristic of Factor XIII deficiency.\n\nThe answer is (D)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-008", "question": "A 22-year-old male is brought to the ED after ingesting a rodenticide. He is alert but complains of extreme weakness. Examination reveals generalized flaccid paralysis. ECG shows premature ventricular complexes. Labs show a serum potassium of 1.8 mEq/L. Which toxin is most likely responsible, and what is the mechanism?", "options": ["Arsenic; uncoupling of oxidative phosphorylation", "Thallium; substitution for potassium in ATPase", "Barium; blockade of potassium efflux channels", "Strychnine; glycine receptor antagonism", "Sodium monofluoroacetate; aconitase inhibition"], "answer": "C", "answer_index": 2, "explanation": "Barium carbonate (found in certain rodenticides and ceramics) causes profound hypokalemia by blocking the inward rectifier potassium channels (Kir), preventing potassium efflux from cells, while the Na-K-ATPase continues to pump potassium in. This results in severe intracellular shift of potassium, leading to paralysis and arrhythmias. Treatment requires aggressive potassium replacement.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nThe patient presents with:\n- Rodenticide ingestion\n- Extreme weakness\n- Generalized flaccid paralysis\n- Cardiac arrhythmias (PVCs on ECG)\n- Severe hypokalemia (K+ = 1.8 mEq/L)\n\nThe key finding here is the profound hypokalemia causing flaccid paralysis and cardiac arrhythmias.\n\nLet me evaluate each option:\n\nA. Arsenic - causes GI symptoms, peripheral neuropathy, and affects oxidative phosphorylation, but doesn't typically cause severe hypokalemia.\n\nB. Thallium - can substitute for potassium in Na+/K+-ATPase, causing neurological symptoms and alopecia, but typically causes hyperkalemia initially, not severe hypokalemia.\n\nC. Barium - blocks potassium efflux channels (rectifier K+ channels), preventing potassium from leaving cells. This causes potassium to shift intracellularly, leading to severe hypokalemia. This explains the flaccid paralysis (due to hyperpolarization of muscle membranes) and cardiac arrhythmias. Barium is used in rodenticides.\n\nD. Strychnine - causes convulsions and muscle rigidity (not flaccid paralysis) through glycine receptor antagonism. This doesn't match the presentation.\n\nE. Sodium monofluoroacetate (compound 1080) - inhibits aconitase in the Krebs cycle, causing citrate accumulation and cardiac/neurological toxicity, but doesn't typically cause severe hypokalemia.\n\nThe clinical picture of severe hypokalemia with flaccid paralysis and cardiac arrhythmias following rodenticide ingestion is classic for barium poisoning. Barium blocks potassium channels, preventing K+ efflux from cells, causing intracellular potassium shift and profound hypokalemia.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-009", "question": "A 2-year-old boy presents with failure to thrive and chronic steatorrhea. Examination reveals absent deep tendon reflexes and ataxia. A peripheral blood smear demonstrates numerous acanthocytes. A lipid panel shows extremely low levels of cholesterol and triglycerides, and absent LDL. Which of the following is the primary pathophysiology?", "options": ["Defect in the LDL receptor", "Mutation in the ABCA1 gene", "Microsomal triglyceride transfer protein (MTP) deficiency", "Lipoprotein lipase deficiency", "Apolipoprotein C-II deficiency"], "answer": "C", "answer_index": 2, "explanation": "This is Abetalipoproteinemia (Bassen-Kornzweig syndrome). It is caused by a mutation in the MTP gene, which is required for the assembly and secretion of apoB-containing lipoproteins (Chylomicrons, VLDL, LDL). The absence of these lipoproteins leads to fat malabsorption (steatorrhea), vitamin E deficiency (spinocerebellar degeneration, absent DTRs), and lipid membrane defects (acanthocytosis).", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nClinical Presentation:\n- 2-year-old boy\n- Failure to thrive\n- Chronic steatorrhea (fat malabsorption)\n- Absent deep tendon reflexes\n- Ataxia\n- Acanthocytes on peripheral blood smear\n- Extremely low cholesterol and triglycerides\n- Absent LDL\n\nKey Features Analysis:\n\nThe combination of:\n1. Fat malabsorption (steatorrhea)\n2. Neurological symptoms (absent reflexes, ataxia)\n3. Acanthocytes\n4. Very low/absent lipoproteins (especially LDL)\n\nThis is classic for Abetalipoproteinemia.\n\nEvaluating Options:\n\nA. LDL receptor defect - This causes Familial Hypercholesterolemia with HIGH LDL levels, not absent LDL.\n\nB. ABCA1 mutation - This causes Tangier disease, characterized by very low HDL, orange tonsils, and peripheral neuropathy, but LDL is present.\n\nC. MTP deficiency - Microsomal triglyceride transfer protein is essential for the assembly and secretion of apoB-containing lipoproteins (chylomicrons in intestine, VLDL in liver). Deficiency causes abetalipoproteinemia with absent LDL, VLDL, and chylomicrons, leading to fat malabsorption, fat-soluble vitamin deficiencies (causing neurological problems from vitamin E deficiency), and acanthocytes.\n\nD. Lipoprotein lipase deficiency - Causes Type I hyperlipoproteinemia with HIGH triglycerides and chylomicrons.\n\nE. Apolipoprotein C-II deficiency - Also causes elevated triglycerides and chylomicrons (similar to LPL deficiency).\n\nConclusion:\n\nThe clinical picture perfectly matches abetalipoproteinemia, which is caused by MTP deficiency. This prevents formation of apoB-containing lipoproteins, explaining the absent LDL, fat malabsorption, and subsequent vitamin E deficiency causing neurological symptoms.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-010", "question": "A 40-year-old male with a history of migraine with aura presents with cognitive decline and a recent lacunar stroke. He has no hypertension or vascular risk factors. MRI of the brain reveals extensive white matter hyperintensities, specifically involving the anterior temporal poles and external capsules. Genetic testing would likely reveal a mutation in which gene?", "options": ["NOTCH3", "GLA", "HTRA1", "APP", "COL4A1"], "answer": "A", "answer_index": 0, "explanation": "This is the classic presentation of CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy). The mutation is in the *NOTCH3* gene. The MRI finding of hyperintensities in the anterior temporal poles is highly sensitive and specific for CADASIL, distinguishing it from chronic hypertensive microangiopathy.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Let me analyze this case systematically.\n\nKey clinical features:\n- 40-year-old male\n- History of migraine with aura\n- Cognitive decline\n- Recent lacunar stroke\n- No hypertension or vascular risk factors\n- MRI: extensive white matter hyperintensities involving anterior temporal poles and external capsules\n\nThis presentation is classic for CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy).\n\nThe hallmark features of CADASIL include:\n1. Migraine with aura (often the first symptom)\n2. Recurrent subcortical ischemic strokes/lacunar infarcts\n3. Progressive cognitive decline\n4. Psychiatric disturbances\n5. Characteristic MRI findings: white matter hyperintensities with specific involvement of the anterior temporal poles and external capsules (highly specific for CADASIL)\n6. Onset typically in mid-adulthood\n7. Absence of traditional vascular risk factors\n\nCADASIL is caused by mutations in the NOTCH3 gene on chromosome 19.\n\nLet me consider the other options:\n- GLA: Fabry disease - causes stroke but different presentation\n- HTRA1: CARASIL - autosomal recessive, also causes alopecia and spondylosis\n- APP: Associated with hereditary cerebral amyloid angiopathy\n- COL4A1: Causes porencephaly, hemorrhagic stroke, and other manifestations\n\nThe involvement of anterior temporal poles and external capsules on MRI is pathognomonic for CADASIL, making NOTCH3 the correct answer.\n\nThe answer is (A)"}]